If we get single payer with our current prices, then we're going to go bankrupt. so we'll probably do what Europe does, which is set caps that companies can sell drugs at.
and how has that worked for europe? pharmaceutical companies now have been incentivized to come to the USA: it's actually why high-skill manufacturing is doing well in the USA, while low-skill manufacturing is leaving.
it costs up to 2.6 billion dollars (with the lower estimates, depending on whether or not you factor in opportunity cost, 1.2 billion dollars) to get a new drug onto the market: which is still a somewhat risky investment. however, with massive payouts, there are still enough investors who are willing to assume that risk, especially when we're talking about an easy 20% rate of return. of course you look at European price caps that stifle investment considerably.
the USA is getting ahead in producing new innovative drugs, not JUST the usual micro-genetic changes that supposedly are a "new" drug with it being basically identical, but biotechs and universities are really stepping up.
so in europe, where patent laws are much less strict, generic brands basically copy our processed, refined, FDA approved drugs and sell them at relatively low prices to europe. by doing this, the USA is assuming the entirety of the risk and the regulatory expenses, while Europe gets relatively low-cost healthcare.
it's taken me a little while to work this all out, but it seems as if the USA starts to set price caps and go single payer, investors will leave. after all, who will take a 2.6 billion dollar risk for such low return rates?
this is not a moral argument for or against single payer, but if you want it, you have 2 options:
1. government must subsidize biotechs and pharmaceutical companies to make new drugs, including major tax increases and less efficiency due to the favoring of large entities by government subsidies.
2. we allow pharmaceutical companies to have relative freedom, and we start to dismantle excessive regulation by the FDA.
you can have extreme regulation and safety OR affordable healthcare that won't entirely bankrupt us.